NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial
This randomised placebo-controlled trial (n=54) in people with treatment-resistant depression tested six weeks of daily low-dose oral esketamine and found no greater rise in serum brain-derived neurotrophic factor tha...
Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder
This observational study (n=22) analysed audio transcripts from a 12-week trial of 25 mg COMP360 psilocybin for post-traumatic stress disorder to examine how much participants and support providers spoke during sessio...
FDA Schedules Psychedelics Hearing, Amid New Push for Medical Approval
The Food and Drug Administration has unveiled multiple actions supporting President Donald Trump’s executive order fast-tracking access to psychedelic therapies ... The post FDA Schedules Psychedelics Hearing, Amid Ne...
FDA Schedules Psychedelics Hearing, Amid New Push for Medical Approval
The Food and Drug Administration has unveiled multiple actions supporting President Donald Trump’s executive order fast-tracking access to psychedelic therapies ...
What’s the Deal with the God Molecule?
Here's what you need to know about 5-MeO-DMT [...] Read More... The post What’s the Deal with the God Molecule? appeared first on DoubleBlind Mag.
Psychedelic Policy Briefing: Week of July 13th, 2026
Massachusetts advances a psychedelic therapy pilot program, the FDA finalizes its psychedelic trial guidance and sets a September hearing, the WNBA bans multiple psychedelics, France doses its first Phase III psilocyb...
Psilocybin’s effect on human brain synaptic plasticity
This secondary analysis of a psilocybin neuroimaging trial used [11C]UCB-J PET to measure synaptic density (SV2A) in 15 healthy participants one week after a single dose. A preplanned interim analysis found no signifi...
Tuesday Brunch: New database for therapists and psychiatrists working on post-psychedelic difficulties
How's that for a catchy headline
The Rush for Iboga Looks Different from Gabon
Gabonese civil servant and environmental lawyer Georges Gassita on what the ibogaine rush looks like from inside Gabon: rising prices, new law, and the difference between sharing a medicine and being stripped of it. T...
The Psychedelic Sector Has Grown Up. Wall Street Just Hasn’t Fully Realized It Yet
The sector experienced an early wave of enthusiasm fueled by bold promises, lofty valuations, and the belief that psychedelic medicine would quickly transform mental healthcare. Reality, however, proved more complicat...
Do people hear voices when they take ayahuasca? 5 Questions with social anthropologist David Dupuis
Dupuis discusses how auditory hallucinations during psychedelic trips have been overlooked.
Massachusetts House Advances Psychedelic Therapy Pilot Program
Massachusetts lawmakers have advanced a groundbreaking measure to establish a state-sanctioned psychedelic-assisted therapy pilot program. The move could create a ... The post Massachusetts House Advances Psychedelic ...
Massachusetts House Advances Psychedelic Therapy Pilot Program
Massachusetts lawmakers have advanced a groundbreaking measure to establish a state-sanctioned psychedelic-assisted therapy pilot program. The move could create a ...
One of Psychedelia’s Most Notorious Gurus Is Officially Put on Blast
PLUS, stories about datura, the Huni Kuin, and Oregon's drug policy programs. [...] Read More... The post One of Psychedelia’s Most Notorious Gurus Is Officially Put on Blast appeared first on DoubleBlind Mag.
LSD Just Joined The Establishment
This Week’s Sunday Insider: The most anti-establishment Psychedelic in history is becoming part of the establishment.